COVID’S SILVER BULLET?

Repost from the-highwire-with-del-bigtree/ Dr. Richard Bartlett’s #Covid19 protocol has successfully treated thousands of patients using an asthma drug that has been commonly prescribed in the U.S. for over 25 years. He joins Del in studio for an in-depth interview discussing his “silver bullet” treatment, and why our gov’t health agencies refuse to investigate his simple solutionContinue reading “COVID’S SILVER BULLET?”

Clinical Pharmacology Corner Update: FDA Approves REXULTI (Brexpiprazole)

FDA Approves REXULTI® (Brexpiprazole) for the Treatment of Schizophrenia and Adjunctive Treatment of Major Depressive Disorder   On July 10, 2015, the FDA approved REXULTI (brexpiprazole) immediate-release tablets for the treatment of schizophrenia and the adjunctive treatment of major depressive disorder (MDD). Dosage and Administration Treatment of Schizophrenia: The recommended starting dose for REXULTI in theContinue reading “Clinical Pharmacology Corner Update: FDA Approves REXULTI (Brexpiprazole)”